Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free

New Upgrade:   Dedicated Screeners for Stocks & ETFs

Learn more

DexCom Reports Better-Than-Expected Q4 Results: Details

By Erica Kollmann | February 12, 2026, 5:50 PM

DexCom Inc. (NASDAQ:DXCM) shares were mostly flat in Thursday's extended trading after the company released its fourth-quarter earnings report.  

Here's a look at the details in the report. 

  • Watch the price DXCM action here.

The Details: DexCom reported quarterly earnings of 68 cents per share, which beat the Street estimate of 65 cents, according to data from Benzinga Pro.

Quarterly revenue came in at $1.26 billion, which beat the analyst estimate of $1.25 billion.

U.S. revenue grew 11% and international revenue grew 18% on a reported basis, all on a year-over-year basis.

Outlook: DexCom affirmed its fiscal 2026 revenue outlook for a range of $5.16 billion to $5.25 billion.

DXCM Stock Price: According to data from Benzinga Pro, DexCom stock rose 0.57% to $65.46 in Thursday's extended trading.  

Photo: Shutterstock

Mentioned In This Article

Latest News

13 hours
Oct-27
Oct-21
Oct-21
Oct-21
Oct-15
Oct-14
Oct-12
Oct-08
Oct-07
Oct-07
Oct-06
Oct-02
Sep-28
Sep-28